Gara Jalqabaatti › Lymphoma B-Cell › New York › New York City
Qorannoo klinikaalii Lymphoma B-Cell New York City, NY keessatti
Qorannoo 18 Lymphoma B-Cell f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Namoota walitti qabaa jiraSadarkaa 3
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- fi 1 dabalataa
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Namoota walitti qabaa jiraSadarkaa 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, New York
A Study of ARC-02 in B-cell NHL
Namoota walitti qabaa jiraSadarkaa 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, New York
DALY II USA/ MB-CART2019.1 for DLBCL
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
- Memorial Sloan Kettering, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
Namoota walitti qabaa jiraSadarkaa 2
- Columbia University Irving Medical Center, New York
Study of CAR-T Therapy in Older Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Namoota walitti qabaa jira
- Columbia University, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Namoota walitti qabaa jira
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Qorannoo Lymphoma B-Cell magaalota biroo keessatti
- Houston, TXQorannoo 16
- Chicago, ILQorannoo 13
- Nashville, TNQorannoo 11
- Philadelphia, PAQorannoo 11
- Rochester, MNQorannoo 10
- Milwaukee, WIQorannoo 9
- Baldwin Park, CAQorannoo 9
- Cleveland, OHQorannoo 9
- Boston, MAQorannoo 8
- Salt Lake City, UTQorannoo 8
- Washington, DCQorannoo 7
- Pittsburgh, PAQorannoo 7
Qorannoo biroo New York City keessatti
- Saree OljooQorannoo 136
- Kansara Qara'a Non-Small CellQorannoo 121
- Saree (Gosoota Hunda)Qorannoo 109
- Kansarii ProstateQorannoo 103
- Kansara MetastatikiiQorannoo 93
- Kansarii ColorectalQorannoo 78
- Kansarii OvariiQorannoo 69
- Dhibee QaraQorannoo 60
- Myeloma Baay’eeQorannoo 60
- Kansarii PancreasQorannoo 60
- Kansa EndometiriyaaliiQorannoo 52
- Leukemia Myeloidii HamaaQorannoo 51
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.